Adefovir dipivoxil (Standard)

Overview

Adefovir dipivoxil (Standard) is the analytical standard of Adefovir dipivoxil. This product is intended for research and analytical applications. Adefovir dipivoxil is an orally active adenosine analog and Adefovir prodrug. Adefovir dipivoxil inhibits DNA synthesis , activates the ATR signaling pathway, and disrupts the KCTD12-CDK1 interaction. Adefovir dipivoxil has antiviral activity against PRV , HBV , and orthopoxviruses . Adefovir dipivoxil has inhibitory effects on both lamivudine-resistant and wild-type strains . Adefovir dipivoxil has antitumor activity against lung and colon cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Anti-infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Drug Resistance | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > HBV | Products > Signaling Pathways > Reverse Transcriptase | Products > Signaling Pathways > Orthopoxvirus | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-B0255R
• CAS No.: 142340-99-6
• Molecular Formula: C20H32N5O8P
• Molecular Weight: 501.47
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source